Dr. Steven W. Allen

Paul Szabolcs, MD, received his medical degree summa cum laude at the Semmelweis University School of Medicine in Budapest, Hungary. He completed his training in pediatrics at Bellevue Hospital/NYU Medical Center and subsequently trained in hematology/oncology at the Memorial Sloan Kettering Cancer Center/Cornell-NY Hospital Medical Center in New York City. He received postdoctoral laboratory training at the Memorial Sloan Kettering Cancer Center and at Rockefeller University in the Department of Physiology and Cellular Immunology. Dr. Szabolcs is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Systemic Sclerosis (SSc), Delayed Growth, Infantile Neutropenia, and Wildervanck Syndrome.

Frederico Xavier, MD, MS, is the associate clinical director for the Hemophilia Center of Western Pennsylvania and an associate professor of Pediatrics at the University of Pittsburgh School of Medicine. He is board-certified in Pediatrics and in Pediatric Hematology/Oncology. Dr. Xavier completed his medical degree, pediatric residency, and fellowship training in Brazil. He then completed a pediatric residency in New York, pediatric hematology and oncology fellowship at St. Jude Children’s Hospital, and then a pediatric hemostasis fellowship at the Hospital for Sick Children in Toronto, Ontario, Canada. Dr. Xavier completed a master’s degree in clinical research at the Indiana University-Purdue University Indianapolis. He has published peer-reviewed articles and book chapters in the field of pediatric hemostasis and is currently awarded with a research grant to study inflammation in Hemophilia. Dr. Xavier also sits in the Newborn Screening and Follow-up Technical Advisory Board for the Pennsylvania Department of Health. Dr. Xavier also practices at the Hemophilia Center of Western Pennsylvania, a state and federally-funded 501(c)3 charitable organization that provides comprehensive medical care to the residents of Western Pennsylvania with hemophilia and other bleeding and clotting disorders. The functions of the center include diagnosis and evaluation of individuals with bleeding disorders; treatment of bleeding episodes and complications; education of the patient and family, the community, and other medical providers; communication and advocacy; supervision of home care; and research and data collection. View the full list of Dr. Xavier’s publications on PubMed. Dr. Xavier is rated as a Distinguished provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Hemophilia A, Hemophilic Arthropathy, Hemophilia B, and Von Willebrand Disease (VWD).

James Felker, MD, is a pediatric hematologist/oncologist and is certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics. He is assistant professor of medicine at the University of Pittsburgh School of Medicine. Dr. Felker received his medical degree from New York Medical College and completed his residency at Northwestern University/Ann & Robert H. Lurie Children’s Hospital of Chicago followed by a fellowship in pediatric hematology/oncology and neuro-oncology at Emory University/Children’s Healthcare of Atlanta, Ga. Dr. Felker’s clinical interests include pediatric brain and spinal tumors and clinical trial development. He has published numerous articles in peer-reviewed journals and is a member of the American Society of Pediatric Hematology/Oncology, American Society of Clinical Oncology, Society for Neuro-Oncology, Children’s Oncology Group, and the Pediatric Brain Tumor Consortium. His wife is a pediatric cardiologist at UPMC Children’s and has an interest in long term cardiac outcomes for oncology patients. Together they have two girls and a beagle mutt. Dr Felker enjoys running along the rivers in Pittsburgh while trying to avoid the hills. View the full list of Dr. Felker's publications on PubMed. View Dr. Felker's profile at the University of Pittsburgh School of Medicine – Department of Pediatrics. LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling. Dr. Felker is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Brain Stem Cancer, Diffuse Midline Glioma H3 K27M-Mutant, Glioma, and Medulloblastoma.